Comparison of Metabolic Outcomes in Children Diagnosed with Type 1 Diabetes Through Research Screening (Diabetes Autoimmunity Study in the Young [DAISY]) Versus in the Community.

There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

Abstract

Children with positive islet autoantibodies monitored prospectively avoid metabolic decompensation at type 1 diabetes (T1D) diagnosis. However, the effects of early diagnosis and treatment on preservation of insulin secretion and long-term metabolic control are unknown. We compared characteristics of children detected through research screening (Diabetes Autoimmunity Study in the Young [DAISY]) versus community controls at baseline and, in a subset, 6- and 12-month metabolic outcomes.

Related collections

Author and article information

Journal

Journal ID (iso-abbrev): Diabetes Technol. Ther.

Title: Diabetes technology & therapeutics

Publisher: Mary Ann Liebert Inc

ISSN (Electronic): 1557-8593

ISSN (Print): 1520-9156

Publication date (Electronic): Sep 2015

Volume: 17

Issue: 9

Affiliations

[1 ] 1 Children's Hospital Colorado and University of Colorado Denver , Aurora, Colorado.

[2 ] 2 Barbara Davis Center for Childhood Diabetes, University of Colorado Denver , Aurora, Colorado.

[3 ] 3 Department of Epidemiology, Colorado School of Public Health, University of Colorado , Aurora, Colorado.

Article

DOI: 10.1089/dia.2015.0029

PMC ID: 4555644

PubMed ID: 26317880

SO-VID: 9677e1b1-0199-457b-ba0e-ed24e57ccdd4

History

Data availability:

Comments

Comment on this article

scite_

Cited by 5

See all cited by